Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

NCT05542381 is registered in ClinicalTrials.gov with Virginia Polytechnic Institute and State University as lead sponsor.

NCT NCT05542381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain
Lead sponsor
Virginia Polytechnic Institute and State University
Phase
Not applicable
Overall status
Completed
Start date
December 22, 2022
Completion date
May 1, 2025
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration